このページを印刷する このページを印刷する
Jiangsu Hengrui Medicine Co., Ltd.
ブース番号 L-16 パビリオン
住所 7 Kunlunshan Road, Economic and Technological Development Zone, Lianyungang, Jiangsu, China 222047
TEL 0086-518-81221686
FAX 0086-518-85465746
URL http://www.hrs.com.cn
Email lee_yan@hrs.com.cn
出展品目 Dexmedetomidine HCl Injection新製品
Sevoflurane Inhalation Anesthetic新製品
Letrozole Tablets新製品
Irinotecan HCl Injection
Letrozole
Irinotecan HCl
Dexmedetomidine HCl
Mesna
Desflurane, Liquid for Inhalation
Etoposide
Ifosfamide
Oxaliplatin
Docetaxel
Atracurium Besylate
Cisatracurium Besylate
Ioversol
Iodixanol
Capofungin Acetate
Capecitabine
Gadoteric Acid Meglumine
ロゴ・写真
見どころ Jiangsu Hengrui Medicine Co., Ltd., established in 1970, having over 13000 employees globally, is not only the front-runner in China’s innovative medicine, but also a well-known R&D center of antineoplastics and surgical medicine in China. Its operating income was over USD 1.7 billion in 2015. The company stock was officially listed on the Shanghai Stock Exchange in 2000. All APIs and finished dosage forms have passed national GMP authentication. For APIs, we got approvals from US-FDA, EDQM, PMDA and TGA. For FDFs, we got approvals from US-FDA, EU and PMDA.
共同出展社